IL1B and periodontitis: Similarly, VX765, a caspase-1 inhibitor, reduced the expressions of IL-1β, in PDLCs stimulated with E. coli LPS or P. gingivalis LPS, and decreased the inflammatory responses during periodontitis in vivo [3].